NRX Pharmaceuticals Inc (NRXP) Insider Trading
- $6,352,004.25
- $2,457,270.57
- Dec. 17, 2024
- Daniel C Javitt
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Dec. 17, 2024 | Chairman | 40,000 | $1.17 | Buy | $46,800.00 | |
| Aug. 22, 2023 | Insider | 200,000 | $0.32 | Buy | $64,000.00 | |
| Dec. 16, 2022 | CEO | 50,000 | $1.17 | Buy | $58,500.00 | |
| Dec. 16, 2022 | CFO | 30,000 | $1.10 | Buy | $33,000.00 | |
| Dec. 7, 2022 | Director | 400,000 | $1.00 | Sell | $400,000.00 | |
| Nov. 29, 2022 | Major Shareholder | 13,730 | $1.50 | Sell | $20,595.00 | |
| Nov. 28, 2022 | Director | 1,750 | $1.25 | Buy | $2,187.50 | |
| Nov. 25, 2022 | CFO | 16,337 | $1.11 | Buy | $18,134.07 | |
| Nov. 18, 2022 | Director | 40,408 | $1.10 | Buy | $44,448.80 | |
| Nov. 17, 2022 | Major Shareholder | 33,018 | $1.05 | Sell | $34,668.90 | |
| Nov. 16, 2022 | Director | 287,812 | $0.99 | Buy | $284,933.88 | |
| Nov. 11, 2022 | Major Shareholder | 49,200 | $1.01 | Sell | $49,692.00 | |
| July 29, 2022 | Major Shareholder | 784,063 | $1.01 | Sell | $791,903.63 | |
| June 6, 2022 | Major Shareholder | 115,657 | $0.67 | Sell | $77,490.19 | |
| June 3, 2022 | Major Shareholder | 243,596 | $0.70 | Sell | $170,517.20 | |
| June 1, 2022 | Insider | 100,000 | $58.00 | Buy | $5,800,000.00 | |
| Sept. 15, 2021 | Insider | 40,000 | $11.76 | Sell | $470,400.00 | |
| Aug. 23, 2021 | General Counsel | 33,715 | $13.11 | Sell | $442,003.65 |
Insiders are both buying and selling NRX Pharmaceuticals Inc stock.
The insider traders at NRX Pharmaceuticals Inc are: Daniel C Javitt, Jonathan C Javitt, Chaim Hurvitz, Voorhees Seth Van, Patrick John Flynn, Alessandra Daigneault, Robert Besthof, and Stephen H Willard
The most active insider trader at NRX Pharmaceuticals Inc is Daniel C Javitt with 6 trades.
Daniel C Javitt has sold the most NRX Pharmaceuticals Inc stock with a total value of $1,165,461.92.
Jonathan C Javitt has bought the most NRX Pharmaceuticals Inc stock with a total value of $5,957,600.00.
The most recent insider trade for NRX Pharmaceuticals Inc was on Dec. 17, 2024.
The single biggest insider buy for NRX Pharmaceuticals Inc was from Jonathan C Javitt with a total value of $5,800,000.00 on June 1, 2022.
The single biggest insider sell for NRX Pharmaceuticals Inc was from Daniel C Javitt with a total value of $791,903.63 on July 29, 2022.